Craig-Hallum Initiates Coverage On Acasti Pharma With Buy Rating, Announces Price Target of $6
Craig-Hallum Initiates Coverage On Acasti Pharma With Buy Rating, Announces Price Target of $6
Craig-Hallum以買入評級啓動對Acasti Pharma的報道，宣佈目標股價爲6美元
Craig-Hallum analyst Chase Knickerbocker initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces Price Target of $6.
Craig-Hallum分析師Chase Knickerbocker以買入評級開始對Acasti Pharma（納斯達克股票代碼：ACST）進行報道，並宣佈目標股價爲6美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。